The World Federation of Hemophilia and the Green Cross Corporation signed a three-year agreement on Monday July 25, 2016, to contribute a total of six million international units (IU) of its recombinant FVIII product to the WFH Humanitarian Aid Program.
Dr. Eun Chul Huh, Green Cross President, and Alain Weill, WFH President, signed this agreement during the WFH 2016 World Congress in Orlando, Florida. With multi-year donations—such as this commitment from Green Cross—and a steady flow of treatment products to the WFH network, it will also be possible for people with bleeding disorders in the developing world have access to treatment for emergency situations, acute bleeds, corrective surgeries, and also prophylaxis for young children.
“We are honoured by this commitment by Green Cross to the WFH Humanitarian Aid Program,” said Weill. “This donation will help to improve the lack of access to treatment products in developing countries by providing consistent and predictable access to Treatment for All.”